Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Aug;224(2):119–124. doi: 10.1097/00000658-199608000-00002

The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors.

C H van Eijck 1, S W Lamberts 1, L C Lemaire 1, H Jeekel 1, F T Bosman 1, J C Reubi 1, H A Bruining 1, E P Krenning 1
PMCID: PMC1235331  PMID: 8757373

Abstract

OBJECTIVE: In the present study, the diagnostic value of somatostatin receptor scintigraphy (SRS) was evaluated in the preoperative workup in patients with pancreatic duct cancers and islet cell tumors, as well as in the follow-up of these patients. METHODS: Twenty-six patients with suspected primary pancreatic duct cancers and 48 patients with islet cell tumors were studied. The SRS was performed using the radionuclide-labeled somatostatin analogue 111In-octreotide. Another group of 12 patients who were still alive more than 3 years after pancreaticoduodenectomy for pancreatic duct adenocarcinomas also underwent SRS. RESULTS: In 31 (65%) of 48 patients, the primary pancreatic islet cell tumor as well as its often previously not yet recognized metastases could be visualized. In contrast, none of the 26 pancreatic adenocarcinomas or their metastases could be seen. In 5 of 12 patients who were alive more than 3 years after pancreaticoduodenectomy for pancreatic duct adenocarcinomas, metastatic lesions were visualized at SRS. In retrospect, these patients were not operated on for adenocarcinomas but for "nonfunctioning" islet cell tumors. CONCLUSIONS: The present study supports the concept that SRS has a place in the preoperative differential diagnosis of islet cell tumors and pancreatic duct cancers as well as in the follow-up, especially in those cases in which no tumor histologic analysis was obtained, or the pathologic examination of the tumor tissue had not included special staining procedures for neuroendocrine characteristics. Our results also indicate that the evaluation of the results of investigations on the role of surgery or radiation therapy and chemotherapy or both in pancreatic duct cancer have to be interpreted with caution, if no histologic analysis and staining for neuroendocrine characteristics was performed.

Full text

PDF
119

Images in this article

121Figure 1.
on p.121
121Figure 2.
on p.121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker W. H., Albert R., Bruns C., Breeman W. A., Hofland L. J., Marbach P., Pless J., Pralet D., Stolz B., Koper J. W. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci. 1991;49(22):1583–1591. doi: 10.1016/0024-3205(91)90052-d. [DOI] [PubMed] [Google Scholar]
  2. Bakker W. H., Krenning E. P., Reubi J. C., Breeman W. A., Setyono-Han B., de Jong M., Kooij P. P., Bruns C., van Hagen P. M., Marbach P. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 1991;49(22):1593–1601. doi: 10.1016/0024-3205(91)90053-e. [DOI] [PubMed] [Google Scholar]
  3. Bell G. I., Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993 Jan;16(1):34–38. doi: 10.1016/0166-2236(93)90050-v. [DOI] [PubMed] [Google Scholar]
  4. Blickstein I., Katz Z., Lancet M., Molgilner B. M. The outcome of pregnancies complicated by preterm rupture of the membranes with and without cerclage. Int J Gynaecol Obstet. 1989 Mar;28(3):237–242. doi: 10.1016/0020-7292(89)90724-8. [DOI] [PubMed] [Google Scholar]
  5. Bloom S. R., Polak J. M. Glucagonomas, VIPomas and somatostatinomas. Clin Endocrinol Metab. 1980 Jul;9(2):285–297. doi: 10.1016/s0300-595x(80)80034-x. [DOI] [PubMed] [Google Scholar]
  6. Eriksson B., Arnberg H., Lindgren P. G., Lörelius L. E., Magnusson A., Lundqvist G., Skogseid B., Wide L., Wilander E., Oberg K. Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med. 1990 Aug;228(2):103–113. doi: 10.1111/j.1365-2796.1990.tb00202.x. [DOI] [PubMed] [Google Scholar]
  7. Eriksson B., Skogseid B., Lundqvist G., Wide L., Wilander E., Oberg K. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer. 1990 May 1;65(9):1883–1890. doi: 10.1002/1097-0142(19900501)65:9<1883::aid-cncr2820650902>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  8. Fekete M., Wittliff J. L., Schally A. V. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal. 1989;3(3):137–147. doi: 10.1002/jcla.1860030302. [DOI] [PubMed] [Google Scholar]
  9. Hamid Q. A., Bishop A. E., Rode J., Dhillon A. P., Rosenberg B. F., Reed R. J., Sibley R. K., Polak J. M. Duodenal gangliocytic paragangliomas: a study of 10 cases with immunocytochemical neuroendocrine markers. Hum Pathol. 1986 Nov;17(11):1151–1157. doi: 10.1016/s0046-8177(86)80421-x. [DOI] [PubMed] [Google Scholar]
  10. Kent R. B., 3rd, van Heerden J. A., Weiland L. H. Nonfunctioning islet cell tumors. Ann Surg. 1981 Feb;193(2):185–190. doi: 10.1097/00000658-198102000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Klöppel G., Heitz P. U. Pancreatic endocrine tumors. Pathol Res Pract. 1988 Apr;183(2):155–168. doi: 10.1016/S0344-0338(88)80043-8. [DOI] [PubMed] [Google Scholar]
  12. Krenning E. P., Bakker W. H., Breeman W. A., Koper J. W., Kooij P. P., Ausema L., Lameris J. S., Reubi J. C., Lamberts S. W. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989 Feb 4;1(8632):242–244. doi: 10.1016/s0140-6736(89)91258-0. [DOI] [PubMed] [Google Scholar]
  13. Krenning E. P., Kwekkeboom D. J., Bakker W. H., Breeman W. A., Kooij P. P., Oei H. Y., van Hagen M., Postema P. T., de Jong M., Reubi J. C. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993 Aug;20(8):716–731. doi: 10.1007/BF00181765. [DOI] [PubMed] [Google Scholar]
  14. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990 Nov 1;323(18):1246–1249. doi: 10.1056/NEJM199011013231805. [DOI] [PubMed] [Google Scholar]
  15. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs. Metabolism. 1990 Sep;39(9 Suppl 2):152–155. doi: 10.1016/0026-0495(90)90235-5. [DOI] [PubMed] [Google Scholar]
  16. Lamberts S. W., Hofland L. J., van Koetsveld P. M., Reubi J. C., Bruining H. A., Bakker W. H., Krenning E. P. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab. 1990 Sep;71(3):566–574. doi: 10.1210/jcem-71-3-566. [DOI] [PubMed] [Google Scholar]
  17. Lundberg J. M., Hamberger B., Schultzberg M., Hökfelt T., Granberg P. O., Efendić S., Terenius L., Goldstein M., Luft R. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4079–4083. doi: 10.1073/pnas.76.8.4079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McKinney M., Barrett R. W. Biochemical evidence for somatostatin receptors in murine neuroblastoma clone N1E-115. Eur J Pharmacol. 1989 Mar 29;162(3):397–405. doi: 10.1016/0014-2999(89)90330-0. [DOI] [PubMed] [Google Scholar]
  19. Norton J. A., Sugarbaker P. H., Doppman J. L., Wesley R. A., Maton P. N., Gardner J. D., Jensen R. T. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986 Apr;203(4):352–359. doi: 10.1097/00000658-198604000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Oberg K., Eriksson B., Lundqvist M. Neuroendocrine tumours of the upper gastrointestinal tract and pancreas. Acta Chir Scand Suppl. 1988;541:76–85. [PubMed] [Google Scholar]
  21. Papotti M., Macrí L., Bussolati G., Reubi J. C. Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int J Cancer. 1989 Mar 15;43(3):365–369. doi: 10.1002/ijc.2910430302. [DOI] [PubMed] [Google Scholar]
  22. Reubi J. C., Chayvialle J. A., Franc B., Cohen R., Calmettes C., Modigliani E. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest. 1991 Apr;64(4):567–573. [PubMed] [Google Scholar]
  23. Reubi J. C., Cortès R., Maurer R., Probst A., Palacios J. M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience. 1986 Jun;18(2):329–346. doi: 10.1016/0306-4522(86)90158-2. [DOI] [PubMed] [Google Scholar]
  24. Reubi J. C., Cortès R., Maurer R., Probst A., Palacios J. M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience. 1986 Jun;18(2):329–346. doi: 10.1016/0306-4522(86)90158-2. [DOI] [PubMed] [Google Scholar]
  25. Reubi J. C., Horisberger U., Essed C. E., Jeekel J., Klijn J. G., Lamberts S. W. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology. 1988 Sep;95(3):760–763. doi: 10.1016/s0016-5085(88)80025-8. [DOI] [PubMed] [Google Scholar]
  26. Reubi J. C., Horisberger U., Lang W., Koper J. W., Braakman R., Lamberts S. W. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol. 1989 Feb;134(2):337–344. [PMC free article] [PubMed] [Google Scholar]
  27. Reubi J. C., Häcki W. H., Lamberts S. W. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab. 1987 Dec;65(6):1127–1134. doi: 10.1210/jcem-65-6-1127. [DOI] [PubMed] [Google Scholar]
  28. Reubi J. C., Krenning E., Lamberts S. W., Kvols L. Somatostatin receptors in malignant tissues. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1073–1077. doi: 10.1016/0960-0760(90)90468-z. [DOI] [PubMed] [Google Scholar]
  29. Reubi J. C., Kvols L. K., Waser B., Nagorney D. M., Heitz P. U., Charboneau J. W., Reading C. C., Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res. 1990 Sep 15;50(18):5969–5977. [PubMed] [Google Scholar]
  30. Reubi J. C., Kvols L., Krenning E., Lamberts S. W. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 1990 Sep;39(9 Suppl 2):78–81. doi: 10.1016/0026-0495(90)90217-z. [DOI] [PubMed] [Google Scholar]
  31. Reubi J. C., Kvols L., Krenning E., Lamberts S. W. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 1990 Sep;39(9 Suppl 2):78–81. doi: 10.1016/0026-0495(90)90217-z. [DOI] [PubMed] [Google Scholar]
  32. Reubi J. C., Lang W., Maurer R., Koper J. W., Lamberts S. W. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 1987 Nov 1;47(21):5758–5764. [PubMed] [Google Scholar]
  33. Reubi J. C., Lang W., Maurer R., Koper J. W., Lamberts S. W. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 1987 Nov 1;47(21):5758–5764. [PubMed] [Google Scholar]
  34. Reubi J. C., Maurer R., Klijn J. G., Stefanko S. Z., Foekens J. A., Blaauw G., Blankenstein M. A., Lamberts S. W. High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab. 1986 Aug;63(2):433–438. doi: 10.1210/jcem-63-2-433. [DOI] [PubMed] [Google Scholar]
  35. Reubi J. C., Maurer R., von Werder K., Torhorst J., Klijn J. G., Lamberts S. W. Somatostatin receptors in human endocrine tumors. Cancer Res. 1987 Jan 15;47(2):551–558. [PubMed] [Google Scholar]
  36. Reubi J. C., Maurer R., von Werder K., Torhorst J., Klijn J. G., Lamberts S. W. Somatostatin receptors in human endocrine tumors. Cancer Res. 1987 Jan 15;47(2):551–558. [PubMed] [Google Scholar]
  37. Reubi J. C., Waser B., Foekens J. A., Klijn J. G., Lamberts S. W., Laissue J. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer. 1990 Sep 15;46(3):416–420. doi: 10.1002/ijc.2910460315. [DOI] [PubMed] [Google Scholar]
  38. Reubi J. C., Waser B., Sheppard M., Macaulay V. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer. 1990 Feb 15;45(2):269–274. doi: 10.1002/ijc.2910450211. [DOI] [PubMed] [Google Scholar]
  39. Rohrer L., Raulf F., Bruns C., Buettner R., Hofstaedter F., Schüle R. Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4196–4200. doi: 10.1073/pnas.90.9.4196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sagman U., Mullen J. B., Kovacs K., Kerbel R., Ginsberg R., Reubi J. C. Identification of somatostatin receptors in human small cell lung carcinoma. Cancer. 1990 Nov 15;66(10):2129–2133. doi: 10.1002/1097-0142(19901115)66:10<2129::aid-cncr2820661015>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  41. Schonbrunn A., Tashjian H., Jr Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem. 1978 Sep 25;253(18):6473–6483. [PubMed] [Google Scholar]
  42. Warren W. H., Lee I., Gould V. E., Memoli V. A., Jao W. Paragangliomas of the head and neck: ultrastructural and immunohistochemical analysis. Ultrastruct Pathol. 1985;8(4):333–343. doi: 10.3109/01913128509141522. [DOI] [PubMed] [Google Scholar]
  43. Yamada Y., Kagimoto S., Kubota A., Yasuda K., Masuda K., Someya Y., Ihara Y., Li Q., Imura H., Seino S. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun. 1993 Sep 15;195(2):844–852. doi: 10.1006/bbrc.1993.2122. [DOI] [PubMed] [Google Scholar]
  44. van Eyck C. H., Bruining H. A., Reubi J. C., Bakker W. H., Oei H. Y., Krenning E. P., Lamberts S. W. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors. World J Surg. 1993 Jul-Aug;17(4):444–447. doi: 10.1007/BF01655102. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES